Wockhardt (WOCKPHARMA.NS) Stock Price

Wockhardt Price

NSE·CLOSED
1,906.30
​
Market closed

Over the last 19 years Wockhardt grew revenue by 3.6% annually, reaching 33.73 B INR. Earnings per share have declined at 2.5% per year over the last 19 years. For Wockhardt, the net margin of 6.3% is up versus -7.6% a few years ago. At today's price the dividend yield works out to roughly 0.48%. The payout ratio is around 32% of earnings.

Wockhardt stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wockhardt business model & stock analysis

Wockhardt Ltd. engages in the pharmaceutical business. The company is headquartered in Mumbai, Maharashtra and currently employs 2,740 full-time employees. The firm's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. The company manufactures a range of dosage forms, including sterile injectables and lyophilized products. The firm offers products in therapeutic areas of dermatology, cosmeceuticals, oncology, medical nutrition, osteoarthritis, pain management, nephrology, cough therapy and diabetology. The Company’s products across India includes Citawok, Citawok Forte, Citawok Plus, CONSEGNA 30/70 U-200 CART, CONSEGNA R U-200 CART, DARBOTIN PFS, DECDAN, DECDAN B, DECDAN B Injection, DECDAN LITE CREAM, Emrok, Emrok O, Erliso, FOSCHEK-S, Gabawok NT, GLARITUS CART, GLARITUS DISPO, Glimaday, INOGLA, Livatira, GLARITUS CART and VAL 450. The company has manufacturing and research facilities in India, United States of America and the United Kingdom and a manufacturing facility in Ireland.

Frequently asked questions about Wockhardt

7 analysts currently rate the Wockhardt stock: 0 recommend buying, 2 holding and 5 selling.

Converted at the current exchange rate, the Wockhardt share trades at 17.90 EUR (1,906.30 INR).

The Wockhardt share (WOCKPHARMA.NS) is listed on 2 stock exchanges, including: NSE (Indien) (WOCKPHARMA.NS).

The revenue of Wockhardt is 33.73 B INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Wockhardt is 2.13 B INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Wockhardt is currently 145.43. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Wockhardt stock.

The price-to-sales ratio (P/S) of Wockhardt is currently 9.18. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Wockhardt stock.

The Eulerpool Quality Score for Wockhardt is 1/10.

The ISIN of Wockhardt is INE049B01025. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Wockhardt is WOCKPHARMA.NS. The ticker symbol is used to trade Wockhardt shares on the stock exchange.

Fair ValueTerminal
1,620.36 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
12.31 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Feb 25, 1994
ISIN
INE049B01025
Cusip
Y73505136
Market capitalization
309.75 B INRMega Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
81.78
P/B Ratio
6.27
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
2.97 %
Dividend
Dividend yield
0.00 %
Payout Ratio
33.98 %
Dividend growth Ø5Y
—
Dividend payments per year
2
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Oct 21, 2026, 1:50 AM

Wockhardt Peer Group

Wockhardt Ticker

BSE · WOCKPHARMA.BONSE INDIA · WOCKPHARMA.NS

Wockhardt FIGI

WPL:IN · BBG000C6YZN2WPL:IB · BBG000C6Z0G6WPL:IS · BBG000C702Z7WPL:IG · BBG003NW41P3

All fundamentals and in-depth analysis of Wockhardt

Our stock analysis for Wockhardt stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wockhardt. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.